Patent US4239768A successfully refreshed from Google Patents.
US4239768A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for relieving irritable bowel syndrome symptoms
Assignee: Janssen Pharmaceuticals Inc
•
Filing: 1978-12-22
•
Granted: 1980-12-16
•
Expires: 1998-12-22
Abstract
Abstract A method for alleviating functional intestinal disorders and for treating the discomfort associated therewith and compositions therefor.
Inventors
- 👤 Chris R. Rasmussen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 05:00
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415; C; C07; C07C; C07C335/00; C07C335/30; C07C335/38; C07D; C07D233/00; C07D233/04; C07D233/28; C07D233/30; C07D233/42; C07D233/44
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
50 words
A method for relieving the symptoms associated with irritable bowel syndrome which comprises administering to an animal having said syndrome a therapeutically effective amount of a urea compound represented by the formula ##STR7## wherein X and Y are selected from methyl, ethyl, chloro and bromo; and pharmaceutically acceptable salts thereof.
Claim 2
Independent Claim
50 words
A method for relieving the symptoms associated with irritable bowel syndrome which comprises administering to an animal having said syndrome a therapeutically effective amount of a urea compound represented by the formula ##STR7## wherein X and Y are selected from methyl, ethyl, chloro and bromo; and pharmaceutically acceptable salts thereof.
Claim 3
Independent Claim
54 words
A method for relieving the symptoms associated with irritable bowel syndrome which comprises administering to an animal having said syndrome from 5 to 500 milligrams per unit dose of a urea compound represented by the formula ##STR8## wherein X and Y are selected from methyl, ethyl, chloro, and bromo; and pharmaceutically acceptable salts thereof.
Claim 4
Independent Claim
54 words
A method for relieving the symptoms associated with irritable bowel syndrome which comprises administering to an animal having said syndrome from 5 to 500 milligrams per unit dose of a urea compound represented by the formula ##STR8## wherein X and Y are selected from methyl, ethyl, chloro, and bromo; and pharmaceutically acceptable salts thereof.
Claim 5
Dependent Claim
13 words
A method according to claim 1 in which the urea compound is N-(2,6-dichlorophenyl)-N'-(2-imidazolidinylidene)urea.
Claim 6
Dependent Claim
13 words
A method according to claim 1 in which the urea compound is N-(2,6-dimethylphenyl)-N'-(2-imidazolidinylidene)urea.
Claim 7
Dependent Claim
13 words
A method according to claim 1 in which the urea compound is N-(2,6-dibromophenyl)-N'-(2-imidazolidinylidene)urea.
Claim 8
Dependent Claim
13 words
A method according to claim 1 in which the urea compound is N-(2-chloro-6-methylphenyl)-N'-(2-imidazolidinylidene)urea.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-12-16 | 1984-06-16 | 1984-12-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-12-16 | 1988-06-16 | 1988-12-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-12-16 | 1992-06-16 | 1992-12-16 | $7700.00 | Window Closed / Lapsed |